You are here

free speech

First Amendment takes center stage in DTC price fight

First Amendment takes center stage in DTC price fight

Biopharma Dive

First Amendment

DTC advertising

Flag link:

The FDA and Off-Label Promotion: First Amendment Considerations Addressed (and Rejected) in FDA Memorandum

The FDA and Off-Label Promotion: First Amendment Considerations Addressed (and Rejected) in FDA Memorandum

FDA Law Blog

First Amendment

Flag link:

Blame the FDA for missing-in-action off-label guidelines? Nope, say two lawmakers. It's the HHS

Blame the FDA for missing-in-action off-label guidelines? Nope, say two lawmakers. It's the HHS

Fierce Pharma

Flag link:

Does FDA’s Per Se Prohibition Against Off-Label Promotion Have a Future?

Does FDA’s Per Se Prohibition Against Off-Label Promotion Have a Future?

FDA Law Blog

Flag link:

Another Court Weighs In on Whether Off-Label Promotion is Per Se Illegal; Jury Finds Both Defendants Not Guilty on All Counts

Another Court Weighs In on Whether Off-Label Promotion is Per Se Illegal; Jury Finds Both Defendants Not Guilty on All Counts

FDA Law Blog

Flag link:

Amarin and FDA near settlement on off-label free speech, ask court for 30 more days

Amarin and FDA near settlement on off-label free speech, ask court for 30 more days

Fierce Pharma

Flag link:

Pacira sues for free speech; FDA pulls off-label warning letter. What gives?

Pacira sues for free speech; FDA pulls off-label warning letter. What gives?

Fierce Pharma Marketing

Flag link:

A Victory for Amarin Further Erodes FDA Regulation of Off-label Promotion

A Victory for Amarin Further Erodes FDA Regulation of Off-label Promotion

FDA Law Blog

Flag link:

How The Feds Discourage Prescription Drug Competition

How The Feds Discourage Prescription Drug Competition

Forbes

Flag link:

You're free to speak, FDA tells Amarin in bid to deflate free-speech suit

You're free to speak, FDA tells Amarin in bid to deflate free-speech suit

Fierce Pharma

Flag link:

FDA Tries to Blunt Amarin’s Free-Speech Lawsuit Over Off-Label Info

FDA Tries to Blunt Amarin’s Free-Speech Lawsuit Over Off-Label Info

WSJ Pharmalot

Flag link:

Secret doctor letter shows Amarin's true 'free speech' leanings

Secret doctor letter shows Amarin's true 'free speech' leanings

Fierce Pharma Marketing

Flag link:

To What Extent Should a Drug Maker be Allowed to Convey Off-Label Info?

To What Extent Should a Drug Maker be Allowed to Convey Off-Label Info?

WSJ Pharmalot

Flag link:

Amarin sues U.S. FDA on free speech grounds over off-label speech

Amarin sues U.S. FDA on free speech grounds over off-label speech

Yahoo/Reuters

Flag link:

Back to first principles: a new model for the regulation of drug promotion

Back to first principles: a new model for the regulation of drug promotion

Drug and Device Law

First Amendment

Flag link:

Report claims FDA is behind the times on employees' free speech

Report claims FDA is behind the times on employees' free speech

BioPharma Dive

Flag link:

FDA Proposal Spurs Fight Over Free Speech and Patient Safety

FDA Proposal Spurs Fight Over Free Speech and Patient Safety

WSJ Pharmalot

Flag link:

Free speech, PhRMA? Not in this off-label marketing case, feds say

Free speech, PhRMA? Not in this off-label marketing case, feds say

Fierce Pharma Marketing

Millennium Pharmaceuticals

whistleblower lawsuits

Flag link:

PhRMA jumps into Integrilin off-label case, free-speech arguments at the ready

PhRMA jumps into Integrilin off-label case, free-speech arguments at the ready

Fierce Pharma Marketing

Schering Plough

Millennium Pharmaceuticals

Flag link:

The First Amendment, In Your Medicine Cabinet

The First Amendment, In Your Medicine Cabinet

Forbes

Flag link:

Pages